← All stocks

HAEMONETICS CORP

HAE Net selling
CIK 0000313143 #1362 in the set updated 21 Sep 2026
Bought (120 mo)
$422.50K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$82.08M
$4.45M on a plan · $36.04M straight out of an exercise
Sold at will
$41.59M
157 of 358 sales
Net
−$81.66M
−$41.17M against sales at will

By person

33 insiders · 362 transactions
28.5×

Christopher A. Simon holds 28.5 times base salary in stock. $31.38M of shares against $1.10M in salary for 2026.

Salary from the company's own proxy. The shares are what Christopher A. Simon last reported holding, valued at $70.56, the price Common Stock was last bought or sold at on the open market here, on 10 Nov 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Simon, Christopher
President & CEO
$22.24M (21)
−$22.24M
444,704
0.9774%
$31.38M
+306.0%
Burke William P. Mr.
EVP, Chief Financial Officer
$14.69M (53)
−$14.69M
30,291
0.0666%
$2.14M
+15,046%
Basil Michelle L
EVP and General Counsel
$11.60M (38) scheduled
−$11.60M
68,829
0.1513%
$4.86M
+4,130%
GRANADILLO PEDRO P
Director
$5.26M (27) scheduled
−$5.26M
15,335
0.0337%
$1.08M
−43.9%
KROLL MARK W
Director
$98.78K (1)
$4.38M (27) scheduled
−$4.28M
27,295
0.0600%
$1.93M
+31.3%
GELBMAN RONALD G
Director
$4.26M (25) scheduled
−$4.26M
48,384
0.1063%
$3.41M
−5.0%
MEELIA RICHARD J
Director
$4.03M (5) scheduled
−$4.03M
32,050
0.0704%
$2.26M
+41.9%
Scanlan Jacqueline
SVP, Global Human Resources
$3.75M (31) scheduled
−$3.75M
4,216
0.0093%
$297.48K
−27.6%
Goldstein Dan
VP, Corporate Controller
$2.90M (52) scheduled
−$2.90M
4,447
0.0098%
$313.78K
+85.5%
Dockendorff Charles J
Director
$2.53M (2) scheduled
−$2.53M
7,126
0.0157%
$502.81K
Strong Stewart W
President, Global Hospital
$1.62M (9) scheduled
−$1.62M
18,196
0.0400%
$1.28M
+42.2%
FOOTE SUSAN BARTLETT
Director
$1.56M (29) scheduled
−$1.56M
20,740
0.0456%
$1.46M
+26.4%
Llorens Josep
EVP, Global Manufacturing
$1.05M (14) scheduled
−$1.05M
30,940
0.0680%
$2.18M
MERRIMAN RONALD
Director
$1.03M (3) scheduled
−$1.03M
17,807
0.0391%
$1.26M
0.0%
Lingamneni Anila
EVP, Chief Technology Officer
$935.63K (9) scheduled
−$935.63K
21,331
0.0469%
$1.51M
+1,415%
ABERNATHY ROBERT E
Director
$323.72K (1)
+$323.72K
27,519
0.0605%
$1.94M
Bolorforosh Said
EVP, Chief Technology Officer
$135.50K (3) scheduled
−$135.50K
1,977
0.0043%
$139.50K
Ryding Neil Mr.
EVP, Global Manufacturing
$57.26K (4)
−$57.26K
15,226
0.0335%
$1.07M
+8.9%
Miller Laurie A.
SVP, Human Resources
$40.35K (6)
−$40.35K
40,987
0.0901%
$2.89M
+402.8%
DArecca James
EVP, Chief Financial Officer
54,444
0.1197%
$3.84M
Jesse Sandra
EVP and Chief Legal Officer
48,166
0.1059%
$3.40M
+7.3%
Galvin Roy
EVP, Chief Commercial Officer
39,882
0.0877%
$2.81M
+35,509%
Chan Frank
EVP, Chief Operating Officer
32,936
0.0724%
$2.32M
+12,666%
Selman Byron
President, Global Markets
23,318
0.0513%
$1.65M
+19.7%
Zane Ellen M
Director
21,911
0.0482%
$1.55M
BURZIK CATHERINE M
Director
19,545
0.0430%
$1.38M
Pomeroy Claire
Director
19,410
0.0427%
$1.37M
COYLE MICHAEL J
Director
17,932
0.0394%
$1.27M
Fusco David
EVP, Global Human Resources
16,867
0.0371%
$1.19M
+18.5%
Johnson Lloyd Emerson
Director
15,471
0.0340%
$1.09M
Bryant Diane M
Director
9,664
0.0212%
$681.89K
Maunsell Farris Maryanne
VP, Chief Accounting Officer
6,242
0.0137%
$440.44K
Madaus Martin D
Director
2,538
0.0056%
$179.08K
Insider
Date
Role
Action
Shares
Price
Amount
KROLL MARK W
10 Nov 2025
Director
Buy
1,400
$70.56
$98.78K
ABERNATHY ROBERT E
11 Aug 2020
Director
Buy
4,000
$80.93
$323.72K
Showing 250 of 362 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 390
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 185
Sales at will 157
Transactions with no price 0
Shares from compensation/vesting 3,044,124
Sales filed before the plan box existed 156
History held since 27 Oct 2016